Incidence and Survival of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms in the Contemporary Era - Summary - MDSpire

Trends in the Incidence and Prognosis of Gastro-Entero-Pancreatic Neuroendocrine Tumors in Modern Times

  • By

  • Julie Hallet

  • Léamarie Meloche-Dumas

  • Carlotta Sarzo

  • Colin Court

  • Jessica Armah

  • Anna Ding

  • Wing C. Chan

  • Simron Singh

  • June 3, 2026

Share

Objective:

To examine the incidence and survival of patients diagnosed with gastro-entero-pancreatic neuroendocrine tumors (GEP-NENs) over the past 2 decades.

Key Findings:
  • GEP-NENs have become one of the most prevalent gastrointestinal malignant neoplasms.
  • There has been a significant increase in the incidence of GEP-NENs since the early 2000s.
Interpretation:

Limitations:
  • The study is limited to the Ontario population and may not reflect trends in other jurisdictions.
  • Data is retrospective and may be subject to biases inherent in administrative health datasets.
Conclusion:

The study provides updated epidemiologic data on GEP-NENs, highlighting trends in incidence and survival over the past two decades.

Original Source(s)

Incidence and Survival of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms in the Contemporary Era

  • by Julie Hallet, Léamarie Meloche-Dumas, Carlotta Sarzo, Colin Court, Jessica Armah, Anna Ding, Wing C. Chan, Simron Singh

  • June 3, 2026

Related Content

Circadian rhythms in the tumor microenvironment: spatiotemporal immune regulation and chronotherapeutic opportunities

Impact of multi-channel follow-up as continuous nursing on cancer pain control, adverse reactions, and quality of life in patients with digestive tract tumors: a controlled study of 136 cases

Global research trends and emerging frontiers of intratumoral microbiota in cancer immunotherapy: a bibliometric and visualization analysis